The Alivecor Kardia Band for the Apple Watch enables anyone to perform a medical-grade ECG anywhere.
AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the introduction of the first medical-grade ECG band for the Apple Watch, Kardia Band (pending FDA (510)k clearance, expected availability late spring) along with a new app for smartphones (available now). The Kardia Band for Apple Watch, and new Kardia app, represent a significant breakthrough in proactive heart health by allowing people to discretely capture their ECG anytime, anywhere.
Users can record a single-lead ECG by simply touching Kardia Band’s integrated sensor that communicates with the Watch app, Kardia by AliveCor. The atrial fibrillation (AF) detector then uses Kardia’s automated analysis process (algorithm) to instantly detect the presence of AF in an ECG, the most common cardiac arrhythmia and a leading cause of stroke. Also included is the Normal Detector, which indicates whether your heart rate and rhythm are normal, and the unreadable detector, which tells you when to retake an ECG so physicians receive only the highest quality recordings.
Users can also record voice memos on their Apple Watch to accompany each ECG that give doctors and caregivers a clearer picture of what was happening at the time of the recording — describing symptoms such as palpitations or external factors like caffeine intake. Kardia also integrates seamlessly with Apple’s Health app to include ECG data with steps and calorie intake to provide richer, personal analysis over time.
“Kardia Band for Apple Watch represents both the future of proactive heart health and the introduction of the Wearable MedTech category,” said Vic Gundotra, chief executive officer of AliveCor. “These combined technologies give us the ability to deliver personal reports that provide analysis, insights and actionable advice for the patient and their doctor.”
“The personal, discrete Kardia Band is a perfect fit for Apple Watch. It allows patients to easily measure and record their heart rhythm in real time. This can provide patients with a sense of control—which is vitally important to successful patient engagement in the treatment of chronic disease,” said Kevin R. Campbell, M.D., FACC, North Carolina Heart and Vascular UNC Healthcare, clinical cardiac electrophysiology assistant professor, UNC Department of Medicine, Division of Cardiology, and President, K-Roc Consulting, LLC.
Kardia Band is designed for anyone who wants to learn more about their health in addition to people with AF, and doctors who want to bring the latest in proactive heart health technology to their patients and practices. Kardia Band provides caregivers the opportunity to take a more active role in helping their loved one engage in their own care. The Kardia Band is pending 510k clearance and is not currently for sale in the United States.
AliveCor has re-introduced its first device, the AliveCor Mobile ECG, under the new Kardia brand name as Kardia Mobile. This change establishes a family of products and makes the name Kardia synonymous with proactive heart health. Currently, Kardia Mobile works with iPhone, iPad and iPod touch, and most Android OS. The new Kardia app is available now for download for iOS and Android users.
For more information: alivecor.com
1. Based on the number of published clinical studies using Kardia Mobile compared to other smartphone-based EKG devices.